Physician
Infectious Disease
Dr. David L. Paterson, MD
David Paterson practices Infectious Disease. He went to The University of Queensland Medical School. Dr. David L. Paterson is a published physician. He published 100 publications, including: 'Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.'
Publications
- Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
- Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.
- OqxAB, a Quinolone and Olaquindox Efflux Pump, Is Widely Distributed among Multidrug-Resistant Klebsiella pneumoniae Isolates of Human Origin.
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.
- Community-associated extended-spectrum ?-lactamase-producing Escherichia coli infection in the United States.
- Treatment Outcome of Bacteremia due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens.
- Th17 cells mediate clade-specific, serotype-independent mucosal immunity.
- Doubtful Model Utility in Predicting High Vancomycin Minimum Inhibitory Concentration Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Episodes.
- Reducing the development of antibiotic resistance in critical care units.
- Influenza-associated Bacterial Pathogens in Patients with 2009 Influenza A (H1N1) Infection: Impact of Community-Associated Methicillin Resistant Staphylococcus aureus...
- Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand.
- Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro PK/PD model.
- Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant P. aeruginosa at multip...
- New Gram-positive antibiotics: better than vancomycin?
- Therapeutic drug monitoring of antimicrobials.
- Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative ...
- Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns.
- Country-to-Country Transfer of Patients and the Risk of Multi-Resistant Bacterial Infection.
- Community-associated Methicillin-resistant Staphylococcus aureus Causing Orbital Cellulitis in Australian Children.
- Strategies for reduction in duration of antibiotic use in hospitalized patients.
- Performance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates.
- Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase.
- Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role...
- Insights into a Multidrug Resistant Escherichia coli Pathogen of the Globally Disseminated ST131 Lineage: Genome Analysis and Virulence Mechanisms.
- Vancomycin Heteroresistance Is Associated with Reduced Mortality in ST239 Methicillin-Resistant Staphylococcus aureus Blood Stream Infections.
- Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates.
- Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients.
- How soon is now? The urgent need for randomized, controlled trials evaluating treatment of multidrug-resistant bacterial infection.
- Multiresistant Gram-negative infections: a global perspective.
- Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period.
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.
- Enhanced diagnosis of pandemic (H1N1) 2009 influenza infection using molecular and serological testing in intensive care unit patients with suspected influenza.
- Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread.
- Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectant.
- Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.
- Cost-effectiveness of a central venous catheter care bundle.
- Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patient.
- CTX-M-2-producing Salmonella Typhimurium isolated from pediatric patients and poultry in Brazil.
- Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania.
- Transmission of bacterial infections to healthcare workers during intubation and respiratory care of patients with severe pneumonia.
- Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobi...
- First case of bloodstream infection caused by Rhodococcus erythropolis.
- Doripenem.
- Klebsiella pneumoniae Carbapenemase-producing Enterobacteriaceae, Northeast Florida.
- Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 beta-lactamase.
- Activity of temocillin against KPC-producing Klebsiella pneumoniae and Escherichia coli.
- Extensively drug-resistant Acinetobacter baumannii.
- Management of meningitis due to antibiotic-resistant Acinetobacter species.
- In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results f...
- Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli.
- Integron-mediated multidrug resistance in a global collection of nontyphoidal Salmonella enterica isolates.
- Cefepime MIC breakpoint resettlement in gram-negative bacteria.
- Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase-type beta-lactamase by use of a boronic acid compound.
- Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
- Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy.
- Antibiotic resistance--what's dosing got to do with it?
- Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients.
- Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
- Health care-associated pneumonia: identification and initial management in the ED.
- Acinetobacter baumannii: emergence of a successful pathogen.
- Genetic environment of 16S rRNA methylase gene rmtD.
- Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
- Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
- Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit.
- Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
- Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving ...
- Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus.
- Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms.
- Optimizing therapy for infections caused by enterobacteriaceae producing extended-spectrum beta-lactamases.
- Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach.
- A step closer to extreme drug resistance (XDR) in gram-negative bacilli.
- Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.
- Appropriate pharmacokinetic index for outcome in Staphylococcus aureus pneumonia.
- High prevalence of metallo-beta-lactamase and 16S rRNA methylase coproduction among imipenem-resistant Pseudomonas aeruginosa isolates in Brazil.
- Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin.
- Setting and revising antibacterial susceptibility breakpoints.
- Community-acquired extended-spectrum beta-lactamase producers, United States.
- Returning to the pre-antibiotic era in the critically ill: the XDR problem.
- Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
- Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients.
- Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study.
- Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil.
- Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea.
- Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis.
- Simkania negevensis in bronchoalveolar lavage of lung transplant recipients: a possible association with acute rejection.
- Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.
- Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical C...
- In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring A...
- KPC type beta-lactamase, rural Pennsylvania.
- Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia.
- The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species.
- Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.
- Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae.
- Epidemiological profile of linezolid-resistant coagulase-negative staphylococci.
- Effect of a selective decontamination of the digestive tract regimen including parenteral cefepime on establishment of intestinal colonization with vancomycin-resistan...
- Resistance in gram-negative bacteria: enterobacteriaceae.
- Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen.
- Modifying antibiotic prescribing in primary care.
- A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms.
Doctors Specialties
- Internal Medicine
- Infectious Disease
Accepted Insurances
Education
-
University of Pittsburgh Medical Center -
The University of Queensland Medical School
Helpful Reviews
Similar Doctors
|
Dr. Nina M. Fatigati, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neelesh K. Nadkarni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey S. Burket, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah K. McMahon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunil V. Bhat, MD
This Doctor is OpenDoctor Recommended.
|